May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Alcon Custom Cornea Wavefront–Guided Retreatment After Laser in situ Keratomileusis
Author Affiliations & Notes
  • E. Fu
    Ophthalmology, Cole Eye Institute Cleveland Clinic Foundation, Cleveland, OH
  • R.R. Krueger
    Ophthalmology, Cole Eye Institute Cleveland Clinic Foundation, Cleveland, OH
  • M. Chalita
    Brazilian Center of Vision, Sao Paulo, Brazil
  • Footnotes
    Commercial Relationships  E. Fu, None; R.R. Krueger, Alcon, F; Alcon, R; M. Chalita, Alcon, R.
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 549. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      E. Fu, R.R. Krueger, M. Chalita; Alcon Custom Cornea Wavefront–Guided Retreatment After Laser in situ Keratomileusis . Invest. Ophthalmol. Vis. Sci. 2006;47(13):549.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To evaluate the outcome of wavefront–guided laser in situ keratomileusis (LASIK) retreatment in patients who had prior myopic LASIK using conventional (nonwavefront) software.

Methods: : Forty–four eyes of 38 patients who underwent wavefront–guided LASIK retreatment with Alcon CustomCornea (Alcon Laboratories Inc, Fort Worth, TX) were evaluated. Complete ophthalmologic examination, corneal topography, and wavefront measurements were performed. Uncorrected visual acuity (UCVA), best spectacle–corrected visual acuity (BSCVA), manifest refraction, and wavefront analysis were evaluated preoperatively, 1 week, 3 months, and 6 months after surgery. Wavefront measurements were assessed using the LADARWave device. Statistical analysis was performed using the McNemar test and percentage of success.

Results: : One week postoperatively, UCVA was >=20/40 in 91% of eyes (>=20/20 in 31%) and BSCVA was >=20/40 in 100% (>=20/20 in 61%). Three months postopratively, UCVA was >=20/40 in 89% of eyes (>=20/20 in 35%) and BSCVA was >=20/40 in 100% (>=20/20 in 71%). Six months postopratively, UCVA was >=20/40 in 91% of eyes (>=20/20 in 33%) and BSCVA was >=20/40 in 100% (>=20/20 in 73%). At each followup, wavefront analysis showed greater than 50% reduction of defocus, astigmatism, coma, spherical aberration, and horizontal trefoil. Overcorrection most often occurred in trefoil, secondary astigmatism, and quadrafoil.

Conclusions: : Wavefront–guided retreatment following conventional LASIK is effective in reducing total and high–order aberrations. Care must be taken to avoid overcorrection when treating patients with higher amounts of total aberration.

Keywords: refractive surgery: other technologies • refractive surgery: LASIK • clinical (human) or epidemiologic studies: outcomes/complications 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×